$3.33 -0.06 (-1.77%) Orexigen Therapeutics Inc - NASDAQ

Jan. 13, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 3.33
Trade Time: Jan 13 04:00 PM Eastern Daylight Time
Change: -0.06 (-1.77%)
Prev Close: 3.39
Open: 3.49
Bid: 3.31
Ask: 3.33
  1. Orexigen Rises After Update On 2017 Priorities

    TalkMarkets | Jan. 5, 2017 | 17:36PM EST
  2. Seth Klarman's Largest New Buys and Adds

    GuruFocus | Feb. 15, 2016 | 16:25PM EST
  3. Benzinga's Top Initiations

    Benzinga | Dec. 11, 2015 | 09:58AM EST
  4. Zafgen Plunges On Death In Obesity-Drug Trial

    IBD | Dec. 2, 2015 | 15:20PM EST
  5. Value Investing in BioPharma

    GuruFocus | Nov. 18, 2015 | 13:14PM EST
  6. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 16, 2015 | 07:13AM EST
  7. Seth Klarman Buys Pharmaceutical Company's Shares to Fund International Drug Launch

    GuruFocus | Oct. 12, 2015 | 16:36PM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 12, 2015 | 07:15AM EST
  9. Mid-Morning Market Update: Markets Mixed; FedEx Earnings Miss Estimates

    Benzinga | Sep. 16, 2015 | 09:25AM EST
  10. Mid-Morning Market Update: Markets Mostly Flat; Krispy Kreme Misses Q2 Estimates

    Benzinga | Sep. 10, 2015 | 09:14AM EST
  11. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 6, 2015 | 07:12AM EST
  12. Orexigen Announces Korean Distributorship Agreement with Kwang Dong Pharmaceutical Company

    Benzinga | Aug. 6, 2015 | 05:59AM EST
  13. Actavis faces suit over diet pill

    IBD | Jun. 5, 2015 | 17:47PM EST
  14. Tuesday's After-Hours Movers: Vertex Pharmaceuticals, Orexigen Therapeutics And More

    Benzinga | May. 12, 2015 | 20:22PM EST
  15. Report: Orexigen Therapeutics Jumped Gun On Contrave Heart Study

    Benzinga | Mar. 3, 2015 | 21:07PM EST
Trading Center